Roger Chin > Latham & Watkins LLP > New York, United States > Lawyer Profile
Latham & Watkins LLP Offices

1271 Avenue of the Americas
NEW YORK
NY 10020
United States
- Firm Profile
- Go to...
Roger Chin

Position
Dr. Roger Chin is a partner in the San Francisco office of Latham & Watkins and a member of the firm’s Litigation & Trial Department. For more than two decades he has focused on litigating life science patent disputes and advising on intellectual property strategy in the pharmaceutical, biotechnology, and medical device industries.
Roger has successfully represented clients in patent cases through preliminary injunction motions, summary judgment, trial, and appeal. He has litigated technology in areas such as chemistry, pharmaceutics, medicine, molecular biology, and genomics.
Roger received his JD from Yale Law School, his MD from Yale Medical School, and his AB summa cum laude in Chemistry from Cornell University. He is admitted to practice law before the Supreme Court of California, the US Courts of Appeal for the Federal and Ninth Circuits, and various US District Courts.
Roger was a member of the Northern District of California Electronic Case Filing (ECF) Taskforce, which implemented one of the first ECF systems in the federal court system in April 2001.
Top Tier Firm Rankings
- Insurance > Advice to policyholders
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- Finance > Capital markets: high-yield debt offerings
- Antitrust > Cartel
- International trade and national security > CFIUS
- Antitrust > Civil litigation/class actions: defense
- Finance > Commercial lending
- Intellectual property > Copyright
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy transactions: electric power
- Energy > Energy transactions: oil and gas
- Environment > Environment: litigation
- Environment > Environment: regulatory
- Environment > Environment: transactional
- Finance > Fintech
- Real estate > Land use/zoning
- Environment > Environment: regulatory
- Dispute resolution > Financial services litigation
- Environment > Environment: regulatory
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Media, technology and telecoms > Media and entertainment: litigation
- Media, technology and telecoms > Media and entertainment: transactional
- Antitrust > Merger control
- Environment > Environment: regulatory
- Environment > Environment: regulatory
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (full coverage)
- Intellectual property > Patents: litigation (International Trade Commission)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Finance > Project finance
- Real estate > Real estate
- Real estate > Real estate investment trusts (REITs)
- Energy > Renewable/alternative power
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Securities litigation: defense
- Industry focus > Sport
- Finance > Structured finance: derivatives and structured products
- Media, technology and telecoms > Technology transactions
- Media, technology and telecoms > Telecoms and broadcast: regulatory
- Media, technology and telecoms > Telecoms and broadcast: transactions
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Tax > US taxes: contentious
- Tax > US taxes: non-contentious
Firm Rankings
- M&A/corporate and commercial > Corporate governance
- International trade and national security > Customs, export controls and economic sanctions
- Energy > Energy regulation: electric power
- Energy > Energy regulation: oil and gas
- Dispute resolution > General commercial disputes
- Government > Government contracts
- Insurance > Insurance: non-contentious
- Dispute resolution > International litigation
- Investment fund formation and management > Private equity funds (including venture capital)
- Healthcare > Service providers
- Finance > Structured finance: securitization
- M&A/corporate and commercial > Venture capital and emerging companies
- Dispute resolution > Financial services litigation
- Healthcare > Health insurers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > International arbitration
- Intellectual property > Trademarks: litigation
- Finance > Financial services regulation
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Dispute resolution > Corporate investigations and white-collar criminal defense
- M&A/corporate and commercial > Shareholder activism